Literature DB >> 33171192

Using retinal function to define ischemic exclusion criteria for animal models of glaucoma.

Bailey G Hannon1, Andrew J Feola2, Brandon G Gerberich3, A Thomas Read4, Mark R Prausnitz5, C Ross Ethier6, Machelle T Pardue7.   

Abstract

Most animal models of glaucoma rely on induction of ocular hypertension (OHT), yet such models can suffer from high IOPs leading to undesirable retinal ischemia. Thus, animals with IOPs exceeding a threshold (e.g. > 60 mmHg) are often excluded from studies. However, due to the intermittent nature of IOP measurements, this approach may fail to detect ischemia. Conversely, it may also inappropriately eliminate animals with IOP spikes that do not induce ischemic damage. It is known that acute ischemia selectively impairs inner retinal function, which results in a reduced b-wave amplitude. Here, we explore the potential of using electroretinography (ERG) to detect ischemic damage in OHT eyes. 74 Brown Norway rats received a unilateral injection of magnetic microbeads to induce OHT, while contralateral eyes served as controls. IOP was measured every 2-3 days for 14 days after microbead injection. Retinal function was evaluated using dark-adapted bright flash ERG (2.1 log cd•s/m2) prior to, and at 7 and 14 days after, injection. We investigated two criteria for excluding animals: (IOP Criterion) a single IOP measurement > 60 mmHg; or (ERG Criterion) a b-wave amplitude below the 99.5% confidence interval for naïve eyes. 49 of 74 rats passed both criteria, 7 of 74 failed both, and 18 passed one criterion but not the other. We suggest that ERG testing can detect unwelcome ischemic damage in animal models of OHT. Since brief IOP spikes do not necessarily lead to ischemic retinal damage, and because extended periods of elevated IOP can be missed, such ERG-based criteria may provide more objective and robust exclusion criteria in future glaucoma studies.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  Electroretinography; Glaucoma; Intraocular pressure; Ischemia; Microbead model; Ocular hypertension

Mesh:

Year:  2020        PMID: 33171192      PMCID: PMC7856020          DOI: 10.1016/j.exer.2020.108354

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.770


  53 in total

1.  Bilateral retinal microglial response to unilateral optic nerve transection in rats.

Authors:  L P Cen; M Han; L Zhou; L Tan; J J Liang; C P Pang; M Zhang
Journal:  Neuroscience       Date:  2015-10-01       Impact factor: 3.590

2.  Rat chronic glaucoma model induced by intracameral injection of microbeads suspended in sodium sulfate-sodium hyaluronate.

Authors:  Yoshiko Matsumoto; Akiyasu Kanamori; Makoto Nakamura; Akira Negi
Journal:  Jpn J Ophthalmol       Date:  2014-03-11       Impact factor: 2.447

3.  Primary open-angle glaucoma presentation at a tertiary unit in Africa: intraocular pressure levels and visual status.

Authors:  M Mafwiri; R J C Bowman; M Wood; J Kabiru
Journal:  Ophthalmic Epidemiol       Date:  2005-10       Impact factor: 1.648

Review 4.  Beta wave of the scotopic (rod) electroretinogram as a measure of the activity of human on-bipolar cells.

Authors:  D C Hood; D G Birch
Journal:  J Opt Soc Am A Opt Image Sci Vis       Date:  1996-03       Impact factor: 2.129

5.  Optic nerve damage in experimental mouse ocular hypertension.

Authors:  Fumihiko Mabuchi; Makoto Aihara; Mason R Mackey; James D Lindsey; Robert N Weinreb
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-10       Impact factor: 4.799

6.  Impact of intraocular pressure on changes of blood flow in the retina, choroid, and optic nerve head in rats investigated by optical microangiography.

Authors:  Zhongwei Zhi; William O Cepurna; Elaine C Johnson; John C Morrison; Ruikang K Wang
Journal:  Biomed Opt Express       Date:  2012-08-24       Impact factor: 3.732

7.  VEGF-A is necessary and sufficient for retinal neuroprotection in models of experimental glaucoma.

Authors:  Richard H Foxton; Arthur Finkelstein; Sauparnika Vijay; Annegret Dahlmann-Noor; Peng T Khaw; James E Morgan; David T Shima; Yin-Shan Ng
Journal:  Am J Pathol       Date:  2013-02-12       Impact factor: 4.307

8.  Changes in retinal morphology, electroretinogram and visual behavior after transient global ischemia in adult rats.

Authors:  Ying Zhao; Bo Yu; Yong-Hui Xiang; Xin-Jia Han; Ying Xu; Kwok-Fai So; An-Ding Xu; Yi-Wen Ruan
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

9.  Telmisartan Reduces Axon Degeneration in Mice With Experimental Glaucoma.

Authors:  Ralph J Hazlewood; John Kuchtey; Hang-Jing Wu; Rachel W Kuchtey
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-05-11       Impact factor: 4.799

View more
  2 in total

1.  Evaluation of Spatially Targeted Scleral Stiffening on Neuroprotection in a Rat Model of Glaucoma.

Authors:  Brandon G Gerberich; Bailey G Hannon; Dillon M Brown; A Thomas Read; Matthew D Ritch; Elisa Schrader Echeverri; Lauren Nichols; Cahil Potnis; Sreesh Sridhar; Maya G Toothman; Stephen A Schwaner; Erin J Winger; Hannah Huang; Gabby S Gershon; Andrew J Feola; Machelle T Pardue; Mark R Prausnitz; C Ross Ethier
Journal:  Transl Vis Sci Technol       Date:  2022-05-02       Impact factor: 3.048

2.  Ocular Hypertension Results in Hypoxia within Glia and Neurons throughout the Visual Projection.

Authors:  Assraa Hassan Jassim; Nana Yaa Nsiah; Denise M Inman
Journal:  Antioxidants (Basel)       Date:  2022-04-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.